Clinical trials: Infants Growth
Body Weight Changes
Clinical Trial of Infant Formula-fed
Compared with breast milk and another commercially available formula, infants' growth rate after 12 weeks' Friso formula with different ways of processing feeding will be assessed.
- Trial name
- NCT02715895
- Testing
- Friso, Wyeth, Breast milk
- Where
- 6 sites in China
- Volunteers
- 216 people, healthy volunteers welcome
- Sponsor
- Maternal and Child Health Care Hospital of Hainan Province
Growth of Infants
Addition to Infant Formula of 2-fucosyllactose (2-FL)
OBJECTIVES: Primary: The primary objective is to determine whether the mean weight gain over a 16-week interval starting on or before 14 days of life differs between infants fed one of two infant formulas as their sole source of…
- Trial name
- 2-FL (NCT03109223)
- Testing
- sole source nutrition
- Where
- 6 sites in United States, Honduras
- Volunteers
- 221 people, healthy volunteers welcome
- Sponsor
- PBM Nutritionals
Malnutrition
Prevention of Linear Growth Failure in Infants and Young Children With Lipid-based Nutrient Supplements (iLiNS-DOSE)
The use of lipid-based nutrients (LNS), such as Nutributter or fortified spread (FS), have been associated with improved growth and development outcomes among infants in Ghana and Malawi.
- Trial name
- iLiNS-DOSE (NCT00945698)
- Testing
- Lipid-based nutrient supplement, 10gM, Lipid-based nutrient supplement, 20gM, Lipid-based Nutrient Supplement, 20gNoM
- Where
- Malawi
- Volunteers
- 1,920 people, healthy volunteers welcome
- Sponsor
- Tampere University
Infant Development
Effects of an Infant Formula on Growth, Safety and Efficacy for Healthy Term Infants
The purpose of this study is to evaluate that a Cow's Milk Based Infant Formula A2 Containing Both OPO and CPP for healthy term infants supports age-appropriate growth.
- Trial name
- NCT04749290
- Testing
- Study Formula
- Where
- 2 sites in China
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- Bunge Loders Croklaan
Infant Newborn
Growth and Tolerance of Young Infants Fed Infant Formulas
This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
- Trial name
- NCT01380886
- Testing
- experimental infant formula with alternate protein source, Infant formula powder
- Where
- 12 sites in United States
- Volunteers
- 209 people, healthy volunteers welcome
- Sponsor
- Abbott Nutrition
Breast Density, Body Composition
Chilean Maternal & Infant Cohort Study II (CHiMINCs-II)
The Chilean Maternal \& Infant Cohort Study II (ChiMINCs II) is an ongoing cohort that is part of the Chilean Maternal and Infant Nutrition Observatory of the South-East area of Santiago, Chile.
- Conditions
- Breast Density, Body Composition, Nutritional Status, Mental Health Issue
- Trial name
- CHiMINCs-II (NCT03920098)
- Testing
- Nutrition and mental health during pregnancy
- Where
- Chile
- Volunteers
- 1,927 people, healthy volunteers welcome
- Sponsor
- Instituto de Nutrición y Tecnología de los Alimentos
Prematurity
Dietary Protein in the Very-low-birth-weight Infant
In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula.
- Trial name
- NCT01208493
- Testing
- preterm infant formula with high protein levels, preterm standard infant formula
- Where
- 4 sites in United States, Belgium and 2 more
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Infant Development
Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas
This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.
- Trial name
- NCT04006236
- Testing
- Experimental Infant Formula, Control Infant Formula
- Where
- 17 sites in United States
- Volunteers
- 245 people, healthy volunteers welcome
- Sponsor
- Abbott Nutrition
Obesity
The Effects of Natural Sugars in Breast Milk on Healthy Infant Growth and Development
This study will investigate the effects of breastfeeding and breastmilk composition on infant gut microbiome development as well as obesity and cognitive outcomes.
- Trial name
- NCT04434027
- Where
- United States
- Volunteers
- 221 people, healthy volunteers welcome
- Sponsor
- University of Southern California
Dietary Modification
Growth of Infants Fed With BabyNes System
The purpose of this study is to assess the growth of infants fed with BabyNes System, compared to the World Health Organization Reference, during the first four months of life.
- Trial name
- NCT01585142
- Testing
- Test formula
- Where
- 4 sites in Switzerland
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Healthy, Term Infants
Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
The purpose of this two-month follow-up study is to continue to follow growth, safety, and other health outcomes of infants fed a new infant formula for term infants or comparator formula.
- Trial name
- NCT04389606
- Testing
- Study Formula (SF), Comparator Formula (CF)
- Where
- 27 sites in United States
- Volunteers
- 311 people, healthy volunteers welcome
- Sponsor
- ByHeart
Microbial Colonization
Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants
The goal of this pilot randomized controlled trial (RCT) is to examine donor human milk (DHM) as a clinical intervention targeted at achieving beneficial microbiome signatures in full-term infants who are exposed to intrapartum…
- Trial name
- PPDHM (NCT05815433)
- Testing
- Donor Human Milk - Nutritional Replacement
- Where
- Canada
- Volunteers
- 105 people, healthy volunteers welcome
- Sponsor
- University of Calgary
Child Malnutrition
ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia
New approaches are needed to prevent growth failure in children from low- and middle-income countries (LMIC). To date, nutrition intervention studies have focused on micronutrient and energy content of complementary foods and…
- Trial name
- OME³Jim (NCT01817634)
- Testing
- Fish powder corn-soy blend'+ Fish oil capsule., Fish powder corn-soy blend + corn oil capsule., Corn-soy blend + fish oil capsule.
- Where
- Ethiopia
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- University Ghent
Infant Nutrition
Effect of the Level of Dietary Protein on Infant Growth
The purpose of this study is to determine whether infants fed a formula with protein levels different than a standard infant formula have similar growth and development.
- Trial name
- NCT00716105
- Testing
- Standard infant formula, Infant formula with different level of proteins
- Where
- 2 sites in United States
- Volunteers
- 405 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Infant, Premature, Kangaroo Mother Care
Effect of Developmental Care on Comfort, Growth, and Oral Feeding Transition in Preterm Infants
This randomized controlled study aims to evaluate the effects of kangaroo care combined with maternal voice and fetal positioning on the comfort, growth, and transition to full oral feeding in preterm infants aged 30 to 34 weeks…
- Conditions
- Infant, Premature, Kangaroo Mother Care, Comfort, Feeding
- Trial name
- KCareInfant (NCT07045402)
- Testing
- Kangaroo Care + Maternal Voice + Fetal Position Group, control group
- Where
- Turkey (Türkiye)
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Fenerbahce University
Infant Malnutrition, Fetal Growth Retardation
DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development
This proposed randomized controlled trial aims to investigate the effect of maternal egg consumption during pregnancy on birth length.
- Trial name
- NCT06405360
- Testing
- Egg consumption
- Where
- Rwanda
- Volunteers
- 464 people, healthy volunteers welcome
- Sponsor
- University of Florida
Malnutrition
Preventing Malnutrition in Children Under Two Years of Age Approach
A study conducted by IFPRI in Haiti provided the first programmatic evidence, using a cluster randomized evaluation design, that preventing child undernutrition in children under two years of age (PM2A) through an integrated…
- Trial name
- NCT01072279
- Testing
- Tubaramure (Burundi), Procomida (Guatemala)
- Where
- 2 sites in Burundi, Guatemala
- Volunteers
- 16,895 people, healthy volunteers welcome
- Sponsor
- International Food Policy Research Institute
Low Birthweight, Stunting
Impact of Benazir Nashonuma Program (BNP) on Maternal and Child Nutritional Status
The purpose of this study is to evaluate the impact of Benazir Nashonuma Program (BNP) which includes specialized nutritious food (SNF) augmented with specific reproductive health interventions during pregnancy on proportion of…
- Conditions
- Low Birthweight, Stunting, Wasting, Malnutrition, Child
- Trial name
- NCT05836961
- Testing
- Benazir Nashonuma Program (BNP)
- Where
- Pakistan
- Volunteers
- 5,500 people, healthy volunteers welcome
- Sponsor
- Aga Khan University
Growth Retardation
The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
This study aims to estimate short-term and long-term effects of time points to cease parenteral nutrition on very preterm infants, such as growth; to estimate the role of insulin-like growth factor 1 in the growth.
- Trial name
- NCT06071403
- Testing
- (enteral feeding volume/ total fluid volume)*100%
- Where
- China
- Volunteers
- 416 people, healthy volunteers welcome
- Sponsor
- Peking University
Healthy
Effect of Lutein in S-26 Gold On Growth And Safety
Study to determine if the addition of lutein to infant formula supports healthy growth and development in healthy full term infants.
- Trial name
- S-26 Gold L (NCT00913406)
- Testing
- Lutein fortification, Standard formula
- Volunteers
- 232 people, healthy volunteers welcome
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer